{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T11:10:16Z","timestamp":1771326616724,"version":"3.50.1"},"reference-count":53,"publisher":"Europa Digital & Publishing","issue":"R","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["EuroIntervention"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.4244\/eijv9sra21","type":"journal-article","created":{"date-parts":[[2014,10,2]],"date-time":"2014-10-02T14:37:26Z","timestamp":1412260646000},"page":"R122-R126","source":"Crossref","is-referenced-by-count":10,"title":["Therapeutic potential of renal sympathetic denervation in patients with chronic heart failure"],"prefix":"10.4244","volume":"9","author":[{"given":"Michael","family":"B\u00f6hm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Ewen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominik","family":"Linz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan-C.","family":"Reil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan H.","family":"Schirmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Ukena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Mahfoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2774","reference":[{"key":"key-2014730135637-0","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1152\/japplphysiol.00832.2009","article-title":"The 2009 Carl Ludwig Lecture: Pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanisms to medical management.","volume":"108","author":"Esler M.","year":"2010","journal-title":"J Appl Physiol."},{"key":"key-2014730135637-1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0165-1838(86)90087-1","article-title":"Effect of afferent renal nerve stimulation on blood pressure, heart rate and noradrenergic activity in conscious rats.","volume":"17","author":"Patel KP.","year":"1986","journal-title":"J Auton Nerv Syst."},{"key":"key-2014730135637-2","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s00392-011-0335-y","article-title":"Sympatho-renal axis in chronic disease.","volume":"100","author":"Sobotka PA.","year":"2011","journal-title":"Clin Res Cardiol."},{"key":"key-2014730135637-3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3109\/10641968909045414","article-title":"Regional norepinephrine turnover in human hypertension.","volume":"11 Suppl 1","author":"Esler M.","year":"1989","journal-title":"Clin Exp Hypertens A."},{"key":"key-2014730135637-4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1161\/01.HYP.0000174243.39897.6c","article-title":"Obstructive sleep apnea-dependent and -independent adrenergic activation in obesity.","volume":"46","author":"Grassi G.","year":"2005","journal-title":"Hypertension."},{"key":"key-2014730135637-5","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1161\/01.CIR.0000103123.66264.FE","article-title":"Impact of type 2 diabetes mellitus on sympathetic neural mechanisms in hypertension.","volume":"108","author":"Huggett RJ.","year":"2003","journal-title":"Circulation."},{"key":"key-2014730135637-6","first-page":"R298","article-title":"Role of renal nerves in sodium retention of cirrhosis and congestive heart failure.","volume":"260","author":"DiBona GF.","year":"1991","journal-title":"Am J Physiol."},{"key":"key-2014730135637-7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0031-6997(25)06662-1","article-title":"Beta 1- and beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure.","volume":"43","author":"Brodde OE.","year":"1991","journal-title":"Pharmacol Rev."},{"key":"key-2014730135637-8","doi-asserted-by":"publisher","first-page":"99S","DOI":"10.1016\/S0895-7061(00)00225-9","article-title":"The sympathetic system and hypertension.","volume":"13","author":"Esler M.","year":"2000","journal-title":"Am J Hypertens."},{"key":"key-2014730135637-9","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.jacc.2009.03.061","article-title":"Sympathetic nervous system activation in human heart failure: clinical implications of an updated model.","volume":"54","author":"Floras JS.","year":"2009","journal-title":"J Am Coll Cardiol."},{"key":"key-2014730135637-10","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1161\/01.HYP.29.3.715","article-title":"The cardiac beta-adrenoceptor-mediated signaling pathway and its alterations in hypertensive heart disease.","volume":"29","author":"Castellano M.","year":"1997","journal-title":"Hypertension."},{"key":"key-2014730135637-11","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1056\/NEJM198409273111303","article-title":"Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure.","volume":"311","author":"Cohn JN.","year":"1984","journal-title":"N Engl J Med."},{"key":"key-2014730135637-12","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/0002-8703(87)90318-8","article-title":"Predicting survival for an individual with congestive heart failure using the plasma norepinephrine concentration.","volume":"114","author":"Rector TS.","year":"1987","journal-title":"Am Heart J."},{"key":"key-2014730135637-13","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1096\/fasebj.4.11.2165947","article-title":"Turning off the signal: desensitization of beta-adrenergic receptor function.","volume":"4","author":"Hausdorff WP.","year":"1990","journal-title":"FASEB J."},{"key":"key-2014730135637-14","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1161\/01.RES.59.3.297","article-title":"Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure.","volume":"59","author":"Bristow MR.","year":"1986","journal-title":"Circ Res."},{"key":"key-2014730135637-15","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/oxfordjournals.eurheartj.a062577","article-title":"Reduction of beta-adrenoceptor density and evaluation of positive inotropic responses in isolated, diseased human myocardium.","volume":"9","author":"B\u00f6hm M.","year":"1988","journal-title":"Eur Heart J."},{"key":"key-2014730135637-16","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1161\/01.CIR.82.4.1249","article-title":"Increase of Gi alpha in human hearts with dilated but not ischemic cardiomyopathy.","volume":"82","author":"B\u00f6hm M.","year":"1990","journal-title":"Circulation."},{"key":"key-2014730135637-17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1172\/JCI113569","article-title":"Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart.","volume":"82","author":"Feldman AM.","year":"1988","journal-title":"J Clin Invest."},{"key":"key-2014730135637-18","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1161\/01.RES.74.2.206","article-title":"Expression of beta-arrestins and beta-adrenergic receptor kinases in the failing human heart.","volume":"74","author":"Ungerer M.","year":"1994","journal-title":"Circ Res."},{"key":"key-2014730135637-19","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1161\/01.CIR.87.2.454","article-title":"Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart.","volume":"87","author":"Ungerer M.","year":"1993","journal-title":"Circulation."},{"key":"key-2014730135637-20","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1161\/01.HYP.22.5.715","article-title":"Cardiac adenylyl cyclase, beta-adrenergic receptors, and G proteins in salt-sensitive hypertension.","volume":"22","author":"B\u00f6hm M.","year":"1993","journal-title":"Hypertension."},{"key":"key-2014730135637-21","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1161\/01.HYP.24.6.653","article-title":"Beta-adrenergic neuroeffector mechanisms in cardiac hypertrophy of renin transgenic rats.","volume":"24","author":"B\u00f6hm M.","year":"1994","journal-title":"Hypertension."},{"key":"key-2014730135637-22","first-page":"611","article-title":"Myocardial Gi-protein levels in patients with hypertensive cardiac hypertrophy, ischemic heart disease and cardiogenic shock.","volume":"30","author":"B\u00f6hm M.","year":"1996","journal-title":"Cardiovasc Res."},{"key":"key-2014730135637-23","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1161\/01.HYP.25.5.954","article-title":"Treatment in hypertensive cardiac hypertrophy, I. Neuropeptide Y and beta-adrenoceptors.","volume":"25","author":"B\u00f6hm M.","year":"1995","journal-title":"Hypertension."},{"key":"key-2014730135637-24","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1161\/01.HYP.25.5.962","article-title":"Treatment in hypertensive cardiac hypertrophy, II. Postreceptor events.","volume":"25","author":"B\u00f6hm M.","year":"1995","journal-title":"Hypertension."},{"key":"key-2014730135637-25","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1161\/01.CIR.92.10.3006","article-title":"Dose-dependent dissociation of ACE-inhibitor effects on blood pressure, cardiac hypertrophy, and beta-adrenergic signal transduction.","volume":"92","author":"B\u00f6hm M.","year":"1995","journal-title":"Circulation."},{"key":"key-2014730135637-26","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/BF00512942","article-title":"Increased sensitivity to alpha-adrenoceptor stimulation but intact purinergic and muscarinergic effects in prehypertensive cardiac hypertrophy of spontaneously hypertensive rats.","volume":"333","author":"B\u00f6hm M.","year":"1986","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."},{"key":"key-2014730135637-27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/sj.bjp.0701615","article-title":"Effects of quinapril, losartan and hydralazine on cardiac hypertrophy and beta-adrenergic neuroeffector mechanisms in transgenic (mREN2)27 rats.","volume":"123","author":"Zolk O.","year":"1998","journal-title":"Br J Pharmacol."},{"key":"key-2014730135637-28","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1161\/01.CIR.92.10.3006","article-title":"Dose-dependent dissociation of ACE-inhibitor effects on blood pressure, cardiac hypertrophy, and beta-adrenergic signal transduction.","volume":"92","author":"B\u00f6hm M.","year":"1995","journal-title":"Circulation."},{"key":"key-2014730135637-29","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/S0002-9149(84)80208-8","article-title":"Comparison of myocardial catecholamine balance in chronic congestive heart failure and in angina pectoris without failure.","volume":"54","author":"Swedberg K.","year":"1984","journal-title":"Am J Cardiol."},{"key":"key-2014730135637-30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1161\/01.CIR.78.1.41","article-title":"In vivo measurement of neuronal uptake of norepinephrine in the human heart.","volume":"78","author":"Goldstein DS.","year":"1988","journal-title":"Circulation."},{"key":"key-2014730135637-31","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/0735-1097(94)00353-R","article-title":"Evidence for reduction of norepinephrine uptake sites in the failing human heart.","volume":"25","author":"B\u00f6hm M.","year":"1995","journal-title":"J Am Coll Cardiol."},{"key":"key-2014730135637-32","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1001\/jama.1996.03530440037034","article-title":"The progression from hypertension to congestive heart failure.","volume":"275","author":"Levy D.","year":"1996","journal-title":"JAMA."},{"key":"key-2014730135637-33","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1161\/HYPERTENSIONAHA.109.142042","article-title":"Sympathetic nervous system modulation of inflammation and remodeling in the hypertensive heart.","volume":"55","author":"Levick SP.","year":"2010","journal-title":"Hypertension."},{"key":"key-2014730135637-34","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1097\/HJH.0b013e328330b845","article-title":"Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values.","volume":"27","author":"Bombelli M.","year":"2009","journal-title":"J Hypertens."},{"key":"key-2014730135637-35","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1001\/jama.292.19.2343","article-title":"Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.","volume":"292","author":"Okin PM.","year":"2004","journal-title":"JAMA."},{"key":"key-2014730135637-36","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0002-9343(03)00158-X","article-title":"A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension.","volume":"115","author":"Klingbeil AU.","year":"2003","journal-title":"Am J Med."},{"key":"key-2014730135637-37","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.jacc.2011.11.034","article-title":"Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension.","volume":"59","author":"Brandt MC.","year":"2012","journal-title":"J Am Coll Cardiol."},{"key":"key-2014730135637-38","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.","volume":"33","author":"McMurray JJ.","year":"2012","journal-title":"Eur Heart J."},{"key":"key-2014730135637-39","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.jacc.2011.11.033","article-title":"Effects of autonomic modulation: more than just blood pressure.","volume":"59","author":"Zile MR.","year":"2012","journal-title":"J Am Coll Cardiol."},{"key":"key-2014730135637-40","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ijcard.2012.09.019","article-title":"First-in-man safety evaluation of renal denervation for chronic systolic heart failure: primary outcome from REACH-Pilot study.","volume":"162","author":"Davies JE.","year":"2013","journal-title":"Int J Cardiol."},{"key":"key-2014730135637-41","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jacc.2008.11.012","article-title":"The cardiorenal syndrome: do we need a change of strategy or a change of tactics?","volume":"53","author":"Jessup M.","year":"2009","journal-title":"J Am Coll Cardiol."},{"key":"key-2014730135637-42","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1161\/HYPERTENSIONAHA.112.193870","article-title":"Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension.","volume":"60","author":"Mahfoud F.","year":"2012","journal-title":"Hypertension."},{"key":"key-2014730135637-43","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1681\/ASN.2011111062","article-title":"Renal denervation in moderate to severe CKD.","volume":"23","author":"Hering D.","year":"2012","journal-title":"J Am Soc Nephrol."},{"key":"key-2014730135637-44","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1161\/CIRCULATIONAHA.110.991869","article-title":"Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study.","volume":"123","author":"Mahfoud F.","year":"2011","journal-title":"Circulation."},{"key":"key-2014730135637-45","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1097\/HJH.0b013e328048d004","article-title":"The sympathetic nervous system and the metabolic syndrome.","volume":"25","author":"Mancia G.","year":"2007","journal-title":"J Hypertens."},{"key":"key-2014730135637-46","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.ejim.2012.04.012","article-title":"Resistant hypertension in visceral obesity.","volume":"23","author":"Holecki M.","year":"2012","journal-title":"Eur J Intern Med."},{"key":"key-2014730135637-47","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1161\/01.CIR.0000103123.66264.FE","article-title":"Impact of type 2 diabetes mellitus on sympathetic neural mechanisms in hypertension.","volume":"108","author":"Huggett RJ.","year":"2003","journal-title":"Circulation."},{"key":"key-2014730135637-48","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.4065\/79.8.1036","article-title":"Obstructive sleep apnea and cardiovascular disease.","volume":"79","author":"Parish JM.","year":"2004","journal-title":"Mayo Clin Proc."},{"key":"key-2014730135637-49","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1161\/HYPERTENSIONAHA.111.173799","article-title":"Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea.","volume":"58","author":"Witkowski A.","year":"2011","journal-title":"Hypertension."},{"key":"key-2014730135637-50","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.hrthm.2011.03.053","article-title":"Negative tracheal pressure during obstructive respiratory events promotes atrial fibrillation by vagal activation.","volume":"8","author":"Linz D.","year":"2011","journal-title":"Heart Rhythm."},{"key":"key-2014730135637-51","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1161\/HYPERTENSIONAHA.112.191965","article-title":"Renal sympathetic denervation suppresses postapneic blood pressure rises and atrial fibrillation in a model for sleep apnea.","volume":"60","author":"Linz D.","year":"2012","journal-title":"Hypertension."},{"key":"key-2014730135637-52","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00392-011-0365-5","article-title":"Renal sympathetic denervation for treatment of electrical storm: first-in-man experience.","volume":"101","author":"Ukena C.","year":"2012","journal-title":"Clin Res Cardiol."}],"container-title":["EuroIntervention"],"original-title":[],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T23:52:18Z","timestamp":1746402738000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.pcronline.com\/eurointervention\/R_issue\/21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":53,"journal-issue":{"issue":"R","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["EIJV9SRA21"],"URL":"https:\/\/doi.org\/10.4244\/eijv9sra21","relation":{},"ISSN":["1774-024X"],"issn-type":[{"value":"1774-024X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}